EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole‐transcriptome defines novel glucose metabolic subtypes in colorectal cancer

Shaohua Li iD, Wei Fang, Jianfeng Zheng, Zhiqiang Peng, Biyue Yu, Chunhui Chen, Yuting Zhang, Wenli Jiang, Shuhui Yuan, Lingqiang Zhang, Xueli Zhang

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shaohua Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glucose, Gene Expression Regulation, Neoplastic, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program, National Natural Science Foundation of China, Key Subject Construction Project of Shanghai Municipal Health Commision.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the most prevalent malignancy of the digestive system. Glucose metabolism plays a crucial role in CRC development. However, the heterogeneity of glucose metabolic patterns in CRC is not well characterized. Here, we classified CRC into specific glucose metabolic subtypes and identified the key regulators. 2228 carbohydrate metabolism‐related genes were screened out from the GeneCards database, 202 of them were identified as prognosis genes in the TCGA database. Based on the expression patterns of the 202 genes, three metabolic subtypes were obtained by the non‐negative matrix factorization clustering method. The C1 subtype had the worst survival outcome and was characterized with higher immune cell infiltration and more activation in extracellular matrix pathways than the other two subtypes. The C2 subtype was the most prevalent in CRC and was characterized by low immune cell infiltration. The C3 subtype had the smallest number of individuals and had a better prognosis, with higher levels of NRF2 and TP53 pathway expression. Secreted frizzled‐related protein 2 (SFRP2) and thrombospondin‐2 (THBS2) were confirmed as biomarkers for the C1 subtype. Their expression levels were elevated in high glucose condition, while their knockdown inhibited migration and invasion of HCT 116 cells. The analysis of therapeutic potential found that the C1 subtype was more sensitive to immune and PI3K‐Akt pathway inhibitors than the other subtypes. To sum up, this study revealed a novel glucose‐related CRC subtype, characterized by SFRP2 and THBS2, with poor prognosis but possible therapeutic benefits from immune and targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGlucoseGene Expression Regulation, NeoplasticTranscriptomeHumansPrognosisBiomarkers, TumorThrombospondinsCell MovementGene Expression ProfilingHCT116 CellsSignal TransductionMembrane ProteinsThrombospondin 2

Stichwörter der Autor:innen

CRCSFRP2THBS2glucoseimmune therapiesmolecular subtype

Substanzen

GlucoseBiomarkers, TumorThrombospondinsMembrane ProteinsThrombospondin 2

Autor:innen und Institutionen

  • The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Department of General Surgery, Southern Medical University Affiliated Fengxian Central Hospital, Shanghai, China.
  • State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
  • School of Life Sciences, Hebei University, Baoding, China.

ORCID-Profile: Shaohua Li

Förderung

  • National Key R&D Program
  • National Natural Science Foundation of China
  • Key Subject Construction Project of Shanghai Municipal Health Commision
  • Planned Science Technology Project of Guangzhou

Zitieren

APA

Li, S., Fang, W., Zheng, J., Peng, Z., Yu, B., Chen, C., Zhang, Y., Jiang, W., Yuan, S., Zhang, L., & Zhang, X. (2024). Whole‐transcriptome defines novel glucose metabolic subtypes in colorectal cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18065

Vancouver

Li S, Fang W, Zheng J, Peng Z, Yu B, Chen C, et al. Whole‐transcriptome defines novel glucose metabolic subtypes in colorectal cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18065

BibTeX
@article{Li2024,
  author = {Li, Shaohua and Fang, Wei and Zheng, Jianfeng and Peng, Zhiqiang and Yu, Biyue and Chen, Chunhui and Zhang, Yuting and Jiang, Wenli and Yuan, Shuhui and Zhang, Lingqiang and Zhang, Xueli},
  title = {Whole‐transcriptome defines novel glucose metabolic subtypes in colorectal cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18065}
}
Kostenlos starten →